Literature DB >> 5321762

The use of isoniazid among household contacts of open cases of pulmonary tuberculosis.

T Egsmose, J O Ang'awa, S J Poti.   

Abstract

A controlled and double-blind study to determine the efficacy of isoniazid in preventing the development of pulmonary tuberculosis among the household contacts of open cases of the disease has been carried out in a rural area of Kenya-a financially handicapped country-under realistic field conditions.A one-year course of isoniazid (5-10 mg per kg of body-weight in one daily dose) administered to the contacts of active cases gave a reduction in respect of the excretion of tubercle bacilli of the order of 90% at the end of the year. In the subsequent observation period (2-4 years) both the control and the isoniazid-treated group showed a low and similar rate of adverse findings.Previous studies by the Tuberculosis Chemotherapy and BCG Centre, Nairobi, had revealed that the risk of tuberculosis among household contacts, especially children, was high and, further, that the acceptability of the drug and the regularity of drug-taking were poor among these contacts. Even so, a very considerable prophylactic effect of isoniazid was demonstrated in the present study. It therefore seems justifiable to conclude that the treatment of household contacts with isoniazid could contribute to tuberculosis control in financially handicapped countries, particularly where a tuberculosis case-finding programme is reasonably well established.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5321762      PMCID: PMC2475854     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.

Authors:  S H FEREBEE; F W MOUNT; F J MURRAY; V T LIVESAY
Journal:  Am Rev Respir Dis       Date:  1963-08

2.  Isoniazid prophylaxis in an undeveloped area.

Authors:  G W COMSTOCK
Journal:  Am Rev Respir Dis       Date:  1962-12

3.  Effect of isoniazid prophylaxis in experimental tuberculosis in guinea pigs. Action of isoniazid in vivo.

Authors:  T BJERKEDAL; C E PALMER
Journal:  Am J Hyg       Date:  1962-09

4.  Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.

Authors:  S H FEREBEE; F W MOUNT
Journal:  Am Rev Respir Dis       Date:  1962-04

5.  Prophylactic effects of isoniazid on primary tuberculosis in children; a preliminary report.

Authors:  S FEREBEE; F W MOUNT; A ANASTASIADES
Journal:  Am Rev Tuberc       Date:  1957-12

6.  Preventive effects of isoniazid in the treatment of primary tuberculosis in children.

Authors:  F W MOUNT; S H FEREBEE
Journal:  N Engl J Med       Date:  1961-10-12       Impact factor: 91.245

  6 in total
  17 in total

Review 1.  Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.

Authors:  Molebogeng X Rangaka; Solange C Cavalcante; Ben J Marais; Sok Thim; Neil A Martinson; Soumya Swaminathan; Richard E Chaisson
Journal:  Lancet       Date:  2015-10-26       Impact factor: 79.321

2.  Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone.

Authors:  S Devadatta; J J Dawson; W Fox; B Janardhanam; S Radhakrishna; C V Ramakrishnan; S Velu
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

3.  Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

4.  Tuberculosis in household contacts of infectious cases in Kampala, Uganda.

Authors:  D Guwatudde; M Nakakeeto; E C Jones-Lopez; A Maganda; A Chiunda; R D Mugerwa; J J Ellner; G Bukenya; C C Whalen
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

Review 5.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

Review 6.  Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.

Authors:  Frank Cobelens; Sanne van Kampen; Eleanor Ochodo; Rifat Atun; Christian Lienhardt
Journal:  PLoS Med       Date:  2012-12-18       Impact factor: 11.069

7.  The use of anti-tuberculosis therapy for latent TB infection.

Authors:  Justin T Denholm; Emma S McBryde
Journal:  Infect Drug Resist       Date:  2010-07-21       Impact factor: 4.003

8.  Antituberculosis drug-induced hepatotoxicity in children.

Authors:  Peter R Donald
Journal:  Pediatr Rep       Date:  2011-06-16

9.  Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts.

Authors:  Philip C Hill; Dolly J Jackson-Sillah; Annette Fox; Roger H Brookes; Bouke C de Jong; Moses D Lugos; Ifedayo M Adetifa; Simon A Donkor; Alex M Aiken; Stephen R Howie; Tumani Corrah; Keith P McAdam; Richard A Adegbola
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.